Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1994-1-10
pubmed:abstractText
Zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)-acetic acid], a membrane-permeant fluorophore specific for Zn(II), was used with spectrofluorimetry and video image analysis to reveal and quantify labile intracellular Zn. Zinquin labelled human chronic-lymphocytic-leukaemia lymphocytes, rat splenocytes and thymocytes with a weak diffuse fluorescence that was quenched when intracellular Zn was chelated with NNN'N'-tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN) and was greatly intensified by pretreatment of cells with the Zn ionophore pyrithione and exogenous Zn. There was substantial heterogeneity of labile Zn among ionophore-treated cells, and fluorescence was largely extranuclear. The average contents of labile Zn in human leukaemic lymphocytes, rat splenocytes and rat thymocytes were approx. 20, 31 and 14 pmol/10(6) cells respectively. Morphological changes and internucleosomal DNA fragmentation indicated substantial apoptosis in these cells when the level of intracellular labile Zn was decreased by treatment with TPEN. Conversely, increasing labile Zn by pretreatment with Zn plus pyrithione suppressed both spontaneous DNA fragmentation and that induced by the potent apoptosis-induced agents colchicine and dexamethasone. These results suggest that prevention of apoptosis is a function of labile Zn, and that a reduction below a threshold concentration in this Zn pool induces apoptosis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-13447763, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1394794, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1417802, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1497326, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1502187, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1530564, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1661594, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1666536, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1696113, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1729140, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1781788, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-191056, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-1993365, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2104979, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2187468, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2538708, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2689380, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2785460, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-2804635, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-3600033, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-3885271, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-3919006, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-4975268, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-592026, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-6099114, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-6204848, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-6312454, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-6364704, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-6980885, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257431-7017326
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
296 ( Pt 2)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
403-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8257431-Animals, pubmed-meshheading:8257431-Apoptosis, pubmed-meshheading:8257431-Chelating Agents, pubmed-meshheading:8257431-DNA Damage, pubmed-meshheading:8257431-Ethylenediamines, pubmed-meshheading:8257431-Fluorescent Dyes, pubmed-meshheading:8257431-Humans, pubmed-meshheading:8257431-Kinetics, pubmed-meshheading:8257431-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:8257431-Lymphocytes, pubmed-meshheading:8257431-Microscopy, Fluorescence, pubmed-meshheading:8257431-Pyridines, pubmed-meshheading:8257431-Quinolones, pubmed-meshheading:8257431-Rats, pubmed-meshheading:8257431-Rats, Sprague-Dawley, pubmed-meshheading:8257431-Spectrometry, Fluorescence, pubmed-meshheading:8257431-Spleen, pubmed-meshheading:8257431-T-Lymphocytes, pubmed-meshheading:8257431-Thiones, pubmed-meshheading:8257431-Tosyl Compounds, pubmed-meshheading:8257431-Tumor Cells, Cultured, pubmed-meshheading:8257431-Zinc
pubmed:year
1993
pubmed:articleTitle
Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II).
pubmed:affiliation
Department of Medicine, University of Adelaide, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't